Comparison

Dovitinib European Partner

€42.00
Excl. VAT
Item no. TMO-T6289-5mg
Manufacturer TargetMol
CASRN 405169-16-6
Amount 5mg
Category
Type Molecules
Specific against other
Purity 0,98
Smiles CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias Dovitinib , TKI-258, CHIR-258, CHIR-258 , TKI258
Similar products 405169-16-6
Available
Short Description
Dovitinib (TKI258, CHIR258) is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit, IC50: 1/2 nM), also effective to class IV (FGFR1/3) and class V (VEGFR1-4) RTKs (IC50: 8-13 nM), less potent to EGFR, InsR, EphA2, c-Met, IGF-1R, Tie2, and HER2.
Shipping
cool pack
Storage
-20°
Target names or alias
CHIR-258 , TKI258
Molecular Weight
392, 43
Pathway
Angiogenesis|||Tyrosine Kinase/Adaptors
Target
VEGFR|||FGFR|||FLT|||PDGFR|||c-Kit

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5mg
Available: In stock
Listprice: €42.00
Price: €42.00
available

Delivery expected until 9/4/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close